The binding of CAR-T cells may be limited in space; furthermore, the potency of CAR-T cells may be weakened or lost due to binding with shed MSLN before they reach the tumor cells or release from the cell surface along with shed MSLN. The gene discussed is MSLN; the disease is neoplasm.